Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
cancer immunotherapy
life sciences
merck
2
×
national blog main
pembrolizumab keytruda
2
×
adaptimmune therapeutics
american society of clinical oncology
axel hoos
axitinib
belantamab mafodotin
boston blog main
bristol-myers squibb
cancer
clinical trials
dostarlimab
europe blog main
europe top stories
fda
glaxosmithkline
immunotherapy
kidney cancer
lyell immunopharma
merck kgaa
national
new york
new york blog main
new york top stories
niraparib (zejula)
nivolumab
non-small cell lung cancer
novartis
parp inhibitor
pfizer
philadelphia blog main
philadelphia top stories
raleigh-durham blog main
renal cell carcinoma
sunitinib
synthetic lethality
What
approved
2
×
advanced
approval
blockbuster
cancer
cases
combo
company
drugs
fda
glaxosmithkline
glaxosmithkline's
growth
immunotherapy
keeps
key
kidney
line
long
merck
merck’s
mid
monday
new
nod
notched
nyse
oncology
plans
resurgence
therapy
track
treating
wins
won
years
Language
unset
Current search:
approved
×
biotech
×
merck
×
" pembrolizumab keytruda "
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}